• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RDW 预测 ALT 持续正常的慢性乙型肝炎患者的纤维化。

RDW Predicts Fibrosis in Patients with Chronic Hepatitis B Having Persistently Normal ALT Levels.

机构信息

Department of Internal Medicine, University of Health Sciences - Adana City Research and Training Hospital, Adana, Turkey.

Department of Gastroenterology, University of Health Sciences - Adana City Research and Training Hospital, Adana, Turkey.

出版信息

Ethiop J Health Sci. 2023 Jul;33(4):591-600. doi: 10.4314/ejhs.v33i4.5.

DOI:10.4314/ejhs.v33i4.5
PMID:38784205
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11111190/
Abstract

BACKGROUND

There are studies on the determination of hepatic fibrosis with noninvasive markers but data about liver biopsy results and noninvasive markers in patients with chronic hepatitis B (CHB) are limited. The aim of this study is to determine the relationship between pathological findings and noninvasive markers, and to determine the marker that predicts fibrosis in patients with consistently normal serum alanine aminotransferase (ALT) levels, diagnosed with CHB and undergoing liver biopsy.

METHODS

A total of 122 patients with CHB, 29 of them with HbeAg (+), aged 30 years and older, HBV DNA > 2000 IU / ml, and serum ALT levels measured four times in the last year, were consistently normal, and 93 of them with HbeAg (-) were included in the study. Demographic characteristics of patients, laboratory parameters, histological activity index (HAI) and fibrosis values obtained in liver biopsy, and noninvasive markers (AP (age-platelet) index, APRI (AST/Platelet ratio) and FIB-4 score, neutrophil/lymphocyte ratio, mean platelet volume (MPV) and erythrocyte distribution width (RDW) were recorded.

RESULTS

The relationship between RDW value and fibrosis was statistically significant in the HbeAg (+) group (p<0.001). The relationship between AP index, APRI and FIB-4 score, neutrophil/lymphocyte ratio and MPV with fibrosis was not statistically significant (>0.05 for each).

CONCLUSION

It has been shown that the RDW value can be used to predict fibrosis in CHB patients with normal ALT and HbeAg (+), and the cut-off value for RDW is 12.

摘要

背景

有研究使用非侵入性标志物来确定肝纤维化,但关于慢性乙型肝炎(CHB)患者的肝活检结果和非侵入性标志物的数据有限。本研究旨在确定病理发现与非侵入性标志物之间的关系,并确定在持续正常血清丙氨酸氨基转移酶(ALT)水平、诊断为 CHB 并接受肝活检的患者中预测纤维化的标志物。

方法

共纳入 122 例 CHB 患者,其中 29 例 HbeAg(+),年龄≥30 岁,HBV DNA>2000 IU/ml,过去一年测量了 4 次血清 ALT 水平均正常,其中 93 例 HbeAg(-)纳入研究。记录患者的人口统计学特征、实验室参数、肝活检获得的组织学活动指数(HAI)和纤维化值,以及非侵入性标志物(AP(年龄-血小板)指数、APRI(AST/血小板比值)和 FIB-4 评分、中性粒细胞/淋巴细胞比值、平均血小板体积(MPV)和红细胞分布宽度(RDW)。

结果

HbeAg(+)组中 RDW 值与纤维化之间存在统计学显著关系(p<0.001)。AP 指数、APRI 和 FIB-4 评分、中性粒细胞/淋巴细胞比值和 MPV 与纤维化之间的关系无统计学意义(p>0.05)。

结论

研究表明,RDW 值可用于预测 ALT 正常且 HbeAg(+)的 CHB 患者的纤维化,RDW 的截断值为 12。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27b1/11111190/b51251c05d66/EJHS3304-0591Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27b1/11111190/b51251c05d66/EJHS3304-0591Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27b1/11111190/b51251c05d66/EJHS3304-0591Fig1.jpg

相似文献

1
RDW Predicts Fibrosis in Patients with Chronic Hepatitis B Having Persistently Normal ALT Levels.RDW 预测 ALT 持续正常的慢性乙型肝炎患者的纤维化。
Ethiop J Health Sci. 2023 Jul;33(4):591-600. doi: 10.4314/ejhs.v33i4.5.
2
Clinical usefulness of mean platelet volume and red blood cell distribution width to platelet ratio for predicting the severity of hepatic fibrosis in chronic hepatitis B virus patients.平均血小板体积和红细胞分布宽度与血小板比值对预测慢性乙型肝炎病毒患者肝纤维化严重程度的临床实用性。
Eur J Gastroenterol Hepatol. 2014 Dec;26(12):1320-4. doi: 10.1097/MEG.0000000000000203.
3
Evaluation of APRI and FIB-4 for noninvasive assessment of significant fibrosis and cirrhosis in HBeAg-negative CHB patients with ALT ≤ 2 ULN: A retrospective cohort study.评估APRI和FIB-4对ALT≤2 ULN的HBeAg阴性慢性乙型肝炎患者显著纤维化和肝硬化的无创评估:一项回顾性队列研究。
Medicine (Baltimore). 2017 Mar;96(12):e6336. doi: 10.1097/MD.0000000000006336.
4
Predictors of treatment requirement in HBeAg-negative chronic hepatitis B patients with persistently normal alanine aminotransferase and high serum HBV DNA levels.HBeAg阴性慢性乙型肝炎患者丙氨酸氨基转移酶持续正常但血清HBV DNA水平高时治疗需求的预测因素
Int J Infect Dis. 2016 Nov;52:68-73. doi: 10.1016/j.ijid.2016.09.007. Epub 2016 Sep 9.
5
The gamma-glutamyl transpeptidase-to-platelet ratio predicts liver fibrosis and cirrhosis in HBeAg-positive chronic HBV infection patients with high HBV DNA and normal or mildly elevated alanine transaminase levels in China.在中国,γ-谷氨酰转肽酶与血小板比值可预测乙肝e抗原阳性、乙肝病毒DNA水平高且丙氨酸转氨酶水平正常或轻度升高的慢性乙肝病毒感染患者的肝纤维化和肝硬化情况。
J Viral Hepat. 2016 Nov;23(11):912-919. doi: 10.1111/jvh.12563. Epub 2016 Jul 4.
6
Noninvasive models for the prediction of liver fibrosis in patients with chronic hepatitis B.用于预测慢性乙型肝炎患者肝纤维化的无创模型。
BMC Gastroenterol. 2024 May 24;24(1):183. doi: 10.1186/s12876-024-03270-3.
7
Lower HBV DNA level is associated with more severe liver fibrosis in HBeAg-positive chronic hepatitis B with normal alanine transaminase.HBV DNA 水平较低与 HBeAg 阳性慢性乙型肝炎伴正常丙氨酸氨基转移酶患者更严重的肝纤维化相关。
Virol J. 2024 Jun 4;21(1):127. doi: 10.1186/s12985-024-02368-0.
8
Changes in APRI and FIB-4 in HBeAg-negative treatment-naive chronic hepatitis B patients with significant liver histological lesions receiving 5-year entecavir therapy.恩替卡韦治疗 5 年后有明显肝脏组织学病变的 HBeAg 阴性初治慢性乙型肝炎患者的 APRI 和 FIB-4 的变化。
Clin Exp Med. 2019 Aug;19(3):309-320. doi: 10.1007/s10238-019-00560-z. Epub 2019 May 20.
9
The gamma-glutamyl transferase to platelet ratio and the FIB-4 score are noninvasive markers to determine the severity of liver fibrosis in chronic hepatitis B infection.γ-谷氨酰转移酶与血小板比值及FIB-4评分是用于确定慢性乙型肝炎感染中肝纤维化严重程度的无创性指标。
Br J Biomed Sci. 2018 Jul;75(3):128-132. doi: 10.1080/09674845.2018.1459147. Epub 2018 Jun 12.
10
Diagnostic value of FIB-4, aspartate aminotransferase-to-platelet ratio index and liver stiffness measurement in hepatitis B virus-infected patients with persistently normal alanine aminotransferase.在丙型肝炎病毒感染持续正常丙氨酸氨基转移酶患者中,FIB-4、天门冬氨酸氨基转移酶与血小板比值指数和肝硬度测量的诊断价值。
World J Gastroenterol. 2017 Aug 21;23(31):5746-5754. doi: 10.3748/wjg.v23.i31.5746.

本文引用的文献

1
The liver fibrosis index is superior to the APRI and FIB-4 for predicting liver fibrosis in chronic hepatitis B patients in China.肝纤维化指数优于 APRI 和 FIB-4 指数,可用于预测中国慢性乙型肝炎患者的肝纤维化程度。
BMC Infect Dis. 2019 Oct 22;19(1):878. doi: 10.1186/s12879-019-4459-4.
2
Dynamic Differences Of Red Cell Distribution Width Levels Contribute To The Differential Diagnosis Of Hepatitis B Virus-related Chronic Liver Diseases: A Case-control Study.红细胞分布宽度水平的动态差异有助于乙型肝炎病毒相关慢性肝病的鉴别诊断:一项病例对照研究。
Int J Med Sci. 2019 May 10;16(5):720-728. doi: 10.7150/ijms.31826. eCollection 2019.
3
Noninvasive Indirect Markers of Liver Fibrosis in Alcoholics.
酒精性肝病肝纤维化的无创性间接标志物。
Biomed Res Int. 2019 May 5;2019:3646975. doi: 10.1155/2019/3646975. eCollection 2019.
4
Association of red blood cell distribution width with severity of hepatitis B virus-related liver diseases.红细胞分布宽度与乙型肝炎病毒相关肝病严重程度的关系。
Clin Chim Acta. 2018 Jul;482:155-160. doi: 10.1016/j.cca.2018.04.002. Epub 2018 Apr 6.
5
Diagnostic value of various noninvasive indexes in the diagnosis of chronic hepatic fibrosis.各种无创指标在慢性肝纤维化诊断中的诊断价值。
Eur Rev Med Pharmacol Sci. 2018 Jan;22(2):479-485. doi: 10.26355/eurrev_201801_14198.
6
Diagnostic value of FIB-4, aspartate aminotransferase-to-platelet ratio index and liver stiffness measurement in hepatitis B virus-infected patients with persistently normal alanine aminotransferase.在丙型肝炎病毒感染持续正常丙氨酸氨基转移酶患者中,FIB-4、天门冬氨酸氨基转移酶与血小板比值指数和肝硬度测量的诊断价值。
World J Gastroenterol. 2017 Aug 21;23(31):5746-5754. doi: 10.3748/wjg.v23.i31.5746.
7
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection.EASL 2017 临床实践指南:乙型肝炎病毒感染管理。
J Hepatol. 2017 Aug;67(2):370-398. doi: 10.1016/j.jhep.2017.03.021. Epub 2017 Apr 18.
8
Noninvasive Assessment of Liver Fibrosis By Transient Elastography and FIB4/APRI for Prediction of Treatment Response in Chronic Hepatitis C-An Experience from a Tertiary Care Hospital.通过瞬时弹性成像和FIB4/APRI对肝纤维化进行无创评估以预测慢性丙型肝炎的治疗反应——来自一家三级医疗医院的经验
J Clin Exp Hepatol. 2016 Dec;6(4):282-290. doi: 10.1016/j.jceh.2016.08.001. Epub 2016 Aug 18.
9
Seroprevalence of Human Immunodeficiency Virus, Hepatitis B Virus, Hepatitis C Virus, and Syphilis among Blood Donors at Jigjiga Blood Bank, Eastern Ethiopia.埃塞俄比亚东部吉吉加血库献血者中人类免疫缺陷病毒、乙型肝炎病毒、丙型肝炎病毒和梅毒的血清流行率
Ethiop J Health Sci. 2016 Mar;26(2):153-60. doi: 10.4314/ejhs.v26i2.9.
10
Is the neutrophil to lymphocyte ratio associated with liver fibrosis in patients with chronic hepatitis B?慢性乙型肝炎患者的中性粒细胞与淋巴细胞比值是否与肝纤维化相关?
World J Gastroenterol. 2015 May 14;21(18):5575-81. doi: 10.3748/wjg.v21.i18.5575.